Product Overview

3,4-Dihydro-7-methoxy-4-oxoquinazoline-6-ol acetate is an important pharmaceutical intermediate widely used in the synthesis of antitumor, antiviral, and anti-inflammatory drugs. This compound possesses a stable molecular structure and good reactivity, making it suitable for structural modification and functional validation in the early stages of drug development. It can also be used as a raw material for small-scale, pilot-scale, and commercial production. Its central role in medicinal chemistry research makes it a key starting material for many innovative drug projects, providing customers with efficient and reliable synthetic route support.

Applications

• Drug molecule structure modification and optimization
• Key intermediates in antitumor drug synthesis
• Raw materials for antiviral drug development
• Customized synthesis of pharmaceutical intermediates
• Exploration and optimization of process routes

Quality & Supply Capability

English Name: 3,4-Dihydro-7-methoxy-4-oxoquinazolin-6-yl acetate Properties: This product is a white to off-white solid containing a quinazoline ring structure and acetate groups. It exhibits good thermal and chemical stability and is suitable for various organic synthesis reaction systems. Storage Recommendations: Store in a sealed, light-protected, and dry place, referring to the COA/MSDS for specific requirements. Supply Capabilities: Samples, gram-level, kilogram-level, commercial batches Packaging Specifications: Aluminum foil bags, fluorinated bottles, cardboard drums, customized packaging Document Support: COA, MSDS, HPLC, NMR, etc. We provide a full-process supply service from laboratory samples to industrial-scale production. We can flexibly adjust the supply plan according to the customer's specific requirements for purity, impurity control, packaging specifications, delivery cycle, and quality documents. Simultaneously, we have a comprehensive technical support system to assist customers in completing the entire process from laboratory R&D to pilot-scale amplification, ensuring the feasibility and economy of the process route, and facilitating the smooth progress of projects and the transformation of results.

Why Choose Bioncan

Focused on pharmaceutical intermediates, with extensive experience in the synthesis of quinazoline compounds. Full-scale supply capability covering sample, pilot, intermediate, and commercial production needs. Provides complete quality control documentation to meet GMP and regulatory compliance requirements. Supports customized needs, adjusting purity, impurity limits, and packaging according to customer requirements. Provides process optimization technical support to help customers improve synthesis efficiency and cost control.

Online Consulting

For quotation, inventory, samples, COA, MSDS, or custom synthesis support for CAS 179688-53-0, please submit your requirements. We will respond according to purity, quantity, delivery timeline, and documentation needs.